Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Arovella completes development for cell therapy platform, moves to large scale manufacturing
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Arovella completes development for cell therapy platform, moves to large scale manufacturing
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Arovella completes development for cell therapy platform, moves to large scale manufacturing
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Arovella completes development for cell therapy platform, moves to large scale manufacturing
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Arovella completes development for cell therapy platform, moves to large scale manufacturing
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    • News

  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

  • Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    • News

  • Harris Technology surges ahead with consecutive cash flow positive quarters as demand for low-cost tech grows
    • News

    Harris Technology surges ahead with consecutive cash flow positive quarters as demand for low-cost tech grows

    As Australia has grappled with extreme cost-of-living pressures prompted by rising interest rates and inflation, eCommerce company Harris Technology (ASX: HT8) has demonstrated resilience and strategic prowess to deliver consecutive cash flow positive quarters, expanding its low-cost alternative tech products that have proven hugely popular.  For the quarter ended 31 December 2023, Harris Technology reported

    Read More
    Public
  • Harvest Tech gets additional orders from prominent Five-Eyes customer, expects more in 2024
    • News

    Harvest Tech gets additional orders from prominent Five-Eyes customer, expects more in 2024

    Remote tech provider Harvest Technology Group Limited (ASX: HTG) has confirmed the reception of second and third orders for its Nodestream technology, totalling approximately $380k, from a prominent Five-Eyes defence customer. The Five-Eyes alliance includes Australia, New Zealand, the UK, the US, and Canada. Notably, the entire amount has been received upfront, underlining the confidence

    Read More
    Public
  • They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs
    • News

    They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs

    If you thought only cars could be autonomous (hey, Tesla), think again. Medical device company Control Bionics (ASX: CBL) has wheeled the technology into autonomous wheelchairs, ensuring people with Amyotrophic Lateral Sclerosis (ALS)—a motor neuron disease—live a better, “freer” life.  In support of that, the Company’s wholly-owned US subsidiary has secured a research grant of

    Read More
    Public
  • RocketBoots makes big moves in the UK, locks in four contracts including a Big 4
    • News

    RocketBoots makes big moves in the UK, locks in four contracts including a Big 4

    Customer service software provider for retailers and retail banks, RocketBoots (ASX: ROC) has announced two significant agreements in the UK. The first agreement is with a major retail bank in the UK, part of the prestigious Big 4, while the second is with the Scottish Midland Co-op Society, overseeing around 200 retail grocery stores across

    Read More
    Public
  • Broncos scores big: Expects up to 80% profit growth following 2023 audit
    • News

    Broncos scores big: Expects up to 80% profit growth following 2023 audit

    Just yesterday, Brisbane Broncos’s captain Adam Reynolds left fans holding their breath as he limped off the field, only to be later cleared of any serious injury. However, the real excitement for Broncos enthusiasts lies off the field, as the NRL team reports an uptick in profit and an array of revenue streams that contributed

    Read More
    Public
  • What is Appening? Google terminates contract with Aussie AI without warning
    • News

    What is Appening? Google terminates contract with Aussie AI without warning

    Upon entering January 2024, Google employees likely felt an eerie sense of deja vu as they received emails from their CEO Sundar Pichai, warning them of impending layoffs. Last year, during the same period, Pichai sent out an email informing employees about the “difficult decision” to reduce headcount. Big tech companies have become synonymous with

    Read More
    Public
  • Hold your horses for Stake.com has chosen Racing and Sports Tech to take racing global
    • News

    Hold your horses for Stake.com has chosen Racing and Sports Tech to take racing global

    In what can be considered a massive win, horse racing and wagering company Racing and Sports Technology (ASX: RTH) has bagged the support of global online casino and sportsbook Stake.com—whose sponsorship portfolio includes the likes of Canadian singer Drake and the Stake F1 team, UFC, among others. This partnership will aim to establish racing (and,

    Read More
    Public
  • Spectur records highest revenue month in company history in December, reduced debt while swinging deals
    • News

    Spectur records highest revenue month in company history in December, reduced debt while swinging deals

    Australian-based developer and manufacturer of security, surveillance, warning, environmental monitoring and AI solutions and platforms Spectur (ASX: SP3) disclosed its financial performance for the second quarter of FY24, highlighting notable achievements, including its best revenue month in history, December. For the quarter ended December 31, 2023, Spectur experienced growth in recurring revenue, constituting 63% of

    Read More
    Public
  • Michael Hill removes senior management roles, cuts costs following poor 2023 performance
    • News

    Michael Hill removes senior management roles, cuts costs following poor 2023 performance

    After three years of record results, 2023 finally broke jewellery retailer Michael Hill (ASX: MHJ). Like many Aussies, the Company faced tough retail conditions prompting cost-cutting measures. The fine jewellery brand encountered formidable headwinds due to a bitter cocktail of factors, including the macroeconomic environment impacting consumer sentiment, tough trading conditions, inflated input costs, and

    Read More
    Public
  • Seasonal trends give IncentiaPay revenue a boost, retain members and appointment of Chief Growth Officer
    • News

    Seasonal trends give IncentiaPay revenue a boost, retain members and appointment of Chief Growth Officer

    Prices have risen across the board, leaving little room for discretionary spending. Any help—gift cards, rewards—is appreciated on that front, allowing platforms like entertainment, lifestyle and rewards platform operator IncentiaPay (ASX: INP) to gain a leg up. In Q2 FY24, when seasonal events like Christmas, Black Friday and more prompted consumers to loosen the wallet

    Read More
    Public
  • «
  • ‹
  • 60
  • 61
  • 62
  • 63
  • 64
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.